midazolam has been researched along with casopitant in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bonomo, F; Motta, P; Pagliarusco, S; Pellegatti, M; Pons, N | 1 |
Adams, LM; Fernandes, SA; Fina, P; Fiore, M; Johnson, BM; Pagliarusco, S; Peroni, M; Zamuner, S | 1 |
2 other study(ies) available for midazolam and casopitant
Article | Year |
---|---|
Casopitant: in vitro data and SimCyp simulation to predict in vivo metabolic interactions involving cytochrome P450 3A4.
Topics: Adult; Cells, Cultured; Computer Simulation; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Evaluation, Preclinical; Drug Interactions; Enzyme Induction; Enzyme Inhibitors; Female; Hepatocytes; Humans; Male; Metabolic Clearance Rate; Microsomes, Liver; Middle Aged; Models, Molecular; Neurokinin-1 Receptor Antagonists; Neurotransmitter Agents; Piperazines; Piperidines; Recombinant Proteins; Young Adult | 2011 |
Effect of single and repeat doses of casopitant on the pharmacokinetics of CYP450 3A4 substrates midazolam and nifedipine.
Topics: Adult; Calcium Channel Blockers; Cohort Studies; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Hypnotics and Sedatives; Male; Midazolam; Middle Aged; Neurokinin-1 Receptor Antagonists; Nifedipine; Piperazines; Piperidines; Young Adult | 2010 |